Results 141 to 150 of about 41,657 (198)

Functional and Patient-Reported Outcomes in the Atorvastatin versus Placebo Trial of Hemorrhagic Cerebral Cavernous Malformations: An Exploratory Study.

Cerebrovasc Dis
Sader G, Alcazar-Felix RJ, Jhaveri A, Ali B, Stadnik A, Lee J, Shenkar R, Treine K, McBee N, Girard R, Thompson RE, Hanley DF, Awad I, Flemming KD.   +13 more
europepmc   +1 more source

Toxic interaction between atorvastatin and clarithromycin causing myositis and rhabdomyolysis. [PDF]

Aust Prescr
Hurlbert M, Tay T, Holloway CJ, Girgis L.   +3 more
europepmc   +1 more source

Obicetrapib and ezetimibe enhance LDL receptor-mediated VLDL clearance and regress atherosclerosis on atorvastatin background. [PDF]

J Lipid Res
Inia JA, Zhang LH, Keijzer N, Worms N, van Nieuwkoop-van Straalen A, Ditmarsch M, de Kleer M, Jukema JW, Kastelein JJP, Szarek M, van den Hoek AM, Stokman G, Pieterman EJ, Princen HMG.   +13 more
europepmc   +1 more source

Inflammatory and neurotoxic risk of atorvastatin in diabetic peripheral neuropathy: TNF-centered evidence integrating network toxicology, scRNA-Seq, and cell validation. [PDF]

Front Chem
Yang H, Chen J, Zhu P, Yuan M, Mao S, He Y, Wang X, Wang J, Wang X, Wang X.   +9 more
europepmc   +1 more source

Longitudinal management and novel pharmacological interactions in a patient with HeFH, 21-OHD, and kawasaki disease: a 6-year clinical follow-up. [PDF]

Front Endocrinol (Lausanne)
Zhang Y, Yuan X, Yang X, Chen R.
europepmc   +1 more source

Reengineering statin therapy to protect skeletal muscle: nanocarrier strategies for mitigating mitochondrial dysfunction and myotoxicity. [PDF]

Inflamm Regen
Alabrahim OAA, Allam NK.
europepmc   +1 more source

High-Intensity Atorvastatin and 24-Hour Blood Pressure in Obstructive Sleep Apnea: A Randomized, -Double-Blind, Placebo-Controlled Pilot Study. [PDF]

Am J Hypertens
Bock JM, Vungarala S, Sompalli S, Covassin N, Bukartyk J, Karim S, Louis ES, Wright RS, Singh P, Somers VK.   +9 more
europepmc   +1 more source

Nationwide assessment of community pharmacists' practices and atorvastatin-drug interactions in Egypt. [PDF]

Sci Rep
Maslub MG, Radwan MA, Daud NAA, Abd-Alla ZA, El-Mohamdy MA.   +4 more
europepmc   +1 more source

Comprehensive management of a chronic patient in community pharmacy: impact of Comprehensive Medication Management on health outcomes and quality of life. [PDF]

Farm Comunitarios
Pérez Rodríguez RO, González Valdivieso M, Blázquez Ferrer MA.   +2 more
europepmc   +1 more source